Physician profile
Greg S Baker
NPI 1205924222
$19,867.82
in general payments reported to CMS, 2019-2025
50 companies · $4,212 in 2025
The $4,212 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,003 · 2022: $3,127 · 2023: $4,098 · 2024: $3,428 · 2025: $4,212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,520.83 |
| Education | $216.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,800.37 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $1,635.07 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $1,583.73 | 2021-2025 | Repatha, Otezla, Repatha |
| Otsuka America Pharmaceutical, INC. | $1,512.59 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,297.68 | 2021-2025 | Caplyta |
| Novo Nordisk INC | $1,147.58 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,066.90 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Lundbeck LLC | $1,012.47 | 2021-2025 | Abilify Asimtufii, Rexulti, Vyepti |
| Teva Pharmaceuticals USA, INC. | $825.48 | 2022-2025 | Uzedy |
| Merck Sharp & Dohme LLC | $762.46 | 2021-2025 | Verquvo, Belsomra, Steglatro |
| Abbvie INC. | $709.39 | 2021-2025 | |
| Pfizer INC. | $638.98 | 2021-2025 | |
| Nestle Healthcare Nutrition INC. | $601.75 | 2021-2023 | |
| Astellas Pharma US INC | $560.52 | 2021-2025 | Veozah, Cresemba, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $433.48 | 2021-2025 | Jardiance, Synjardy |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $418.39 | 2021-2025 | |
| Aimmune Therapeutics, INC. | $406.26 | 2024-2025 | Zenpep |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $393.15 | 2021-2025 | Xifaxan, Relistor, Trulance |
| Axsome Therapeutics, INC. | $387.16 | 2023-2024 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $366.64 | 2021-2025 | Eliquis, Camzyos, Cobenfy |
| Corcept Therapeutics | $274.32 | 2022-2025 | Korlym |
| Alkermes, INC. | $250.66 | 2021-2022 | |
| Daiichi Sankyo INC. | $238.06 | 2021-2024 | Injectafer |
| Novartis Pharmaceuticals Corporation | $182.70 | 2021-2024 | |
| Biohaven Pharmaceuticals, INC. | $132.99 | 2021 | |
| Phathom Pharmaceuticals, INC. | $92.65 | 2024-2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $87.83 | 2021-2025 | Trintellix |
| Exact Sciences Corporation | $87.25 | 2024-2025 | Cologuard Collection Kit |
| Nevro Corp. | $77.32 | 2023 | Senza |
| Neurocrine Biosciences, INC. | $74.79 | 2023-2025 | Ingrezza |
| Janssen Pharmaceuticals, INC | $73.91 | 2021 | |
| Baxter Healthcare | $69.06 | 2023 | Hillrom - Life 2000 Ventilation System |
| Mylan Specialty L.P. | $61.03 | 2024 | Yupelri |
| Amarin Pharma, INC. | $59.92 | 2021 | |
| Grifols USA, LLC | $58.81 | 2024-2025 | Prolastin-C Liquid |
| Ironwood Pharmaceuticals, INC | $54.75 | 2023-2024 | Linzess |
| Idorsia Pharmaceuticals US INC | $54.12 | 2022-2023 | Quviviq |
| Abbott Laboratories | $39.72 | 2024 | Proclaim |
| Sumitomo Pharma America, INC. | $37.11 | 2023-2025 | Gemtesa |
| Kowa Pharmaceuticals America, INC. | $34.34 | 2025 | Zoryve |
| Radius Health, INC. | $33.69 | 2023 | Tymlos |
| Vanda Pharmaceuticals INC. | $32.89 | 2021 | |
| Viatris Specialty LLC | $31.40 | 2025 | Yupelri |
| Scilex Pharmaceuticals INC. | $28.29 | 2021 | |
| Verona Pharma, INC. | $27.33 | 2025 | Ohtuvayre |
| Vertex Pharmaceuticals Incorporated | $25.81 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $24.67 | 2021-2024 | Crysvita |
| Smith+Nephew, INC. | $22.29 | 2023 | Grafix Pl |
| Advanced Respiratory, INC | $20.85 | 2021 | |
| Dexcom, INC. | $19.21 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.